Curi Bio

Seattle, United States

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

$10.0M raised

Dec 2025

Series B

Top Investors

National Institutes of HealthDynamk CapitalDreamCISDS Asset ManagementUTC Investment

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Curi Bio raised?

Curi Bio has raised $10.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Curi Bio's investors?

Curi Bio's investors include National Institutes of Health, Dynamk Capital, DreamCIS, DS Asset Management, UTC Investment.

Where is Curi Bio headquartered?

Curi Bio is headquartered in Seattle, United States.

What does Curi Bio do?

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

What stage is Curi Bio at?

Curi Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 2, 2025.

MLA

"Curi Bio — Funding & Investors." VCBacked, December 2, 2025, https://www.vcbacked.co/company/curi-bio. Accessed June 4, 2026.

APA

VCBacked. (2025). Curi Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/curi-bio

Wikipedia (cite web)

{{cite web |title=Curi Bio — Funding & Investors |url=https://www.vcbacked.co/company/curi-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 2, 2025.